GLIMEPIRIDE tablet Bandaríkin - enska - NLM (National Library of Medicine)

glimepiride tablet

carlsbad technology, inc. - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 2 mg - glimepiride tablet usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies ( 14.1) ]. limitations of use glimepiride should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. glimepiride tablets usp are contraindicated in patients with a history of a hypersensitivity reaction to: - glimepiride or any of the product's ingredients [ see warnings and precautions ( 5.2) ]. sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to glimepiride. do not use glimepiride in patients who have a history of an allergic reaction to sulfonamide derivatives. reported hypersensitivity reactions include cutaneous eruptions with or without pruritus as well as more serious reactions (e.g. anaphylax

Glimepiride 4mg tablets Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

glimepiride 4mg tablets

phoenix healthcare distribution ltd - glimepiride - oral tablet - 4mg

Glimepiride 4mg tablets Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

glimepiride 4mg tablets

alliance healthcare (distribution) ltd - glimepiride - oral tablet - 4mg